<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:ns2="http://www.sec.gov/edgar/common">
    <headerData>
        <submissionType>144</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001830053</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>



        </filerInfo>
    </headerData>
    <formData>
        <issuerInfo>
            <issuerCik>0001770121</issuerCik>
            <issuerName>SANA BIOTECHNOLOGY, INC.</issuerName>
            <secFileNumber>001-39941</secFileNumber>
            <issuerAddress>
                <ns2:street1>188 East Blaine Street, Suite 400</ns2:street1>
                <ns2:street2>Suite 400</ns2:street2>
                <ns2:city>Seattle</ns2:city>
                <ns2:stateOrCountry>WA</ns2:stateOrCountry>
                <ns2:zipCode>98102</ns2:zipCode>
            </issuerAddress>
            <issuerContactPhone>(206) 701-7914</issuerContactPhone>
            <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>NATHAN HARDY</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <relationshipsToIssuer>
                <relationshipToIssuer>Former CFO</relationshipToIssuer>
            </relationshipsToIssuer>
        </issuerInfo>
        <securitiesInformation>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <brokerOrMarketmakerDetails>
                <name>Morgan Stanley Smith Barney LLC Executive Financial Services</name>
                <address>
                    <ns2:street1>1 New York Plaza</ns2:street1>
                    <ns2:street2>8th Floor</ns2:street2>
                    <ns2:city>New York</ns2:city>
                    <ns2:stateOrCountry>NY</ns2:stateOrCountry>
                    <ns2:zipCode>10004</ns2:zipCode>
                </address>
            </brokerOrMarketmakerDetails>
            <noOfUnitsSold>25933</noOfUnitsSold>
            <aggregateMarketValue>64959.57</aggregateMarketValue>
            <noOfUnitsOutstanding>223268889</noOfUnitsOutstanding>
            <approxSaleDate>11/25/2024</approxSaleDate>
            <securitiesExchangeName>NASDAQ</securitiesExchangeName>
        </securitiesInformation>
        <securitiesToBeSold>
            <securitiesClassTitle>Class A</securitiesClassTitle>
            <acquiredDate>07/23/2019</acquiredDate>
            <natureOfAcquisitionTransaction>Founder Stock</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>25933</amountOfSecuritiesAcquired>
            <paymentDate>07/23/2019</paymentDate>
            <natureOfPayment>Cash</natureOfPayment>
        </securitiesToBeSold>
        <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>NATHAN HARDY</name>
                <address>
                    <ns2:street1>188 East Blaine Street, Suite 400</ns2:street1>
                    <ns2:street2>Suite 400</ns2:street2>
                    <ns2:city>Seattle</ns2:city>
                    <ns2:stateOrCountry>WA</ns2:stateOrCountry>
                    <ns2:zipCode>98102</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <saleDate>10/21/2024</saleDate>
            <amountOfSecuritiesSold>45796</amountOfSecuritiesSold>
            <grossProceeds>180807.19</grossProceeds>
        </securitiesSoldInPast3Months>
        <noticeSignature>
            <noticeDate>11/25/2024</noticeDate>
            <planAdoptionDates/>
            <signature>/s/ Nathan Richard Hardy</signature>
        </noticeSignature>
    </formData>
</edgarSubmission>
